Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Dabrowka

6 clinical trials in Dabrowka, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Dabrowka at a glance
6
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Dabrowka

Open in trial search
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Psoriatic arthropathy

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Dabrowka

What the registry says about research in the country

01 Rheumatology Research

Groundbreaking clinical trials focusing on psoriatic arthritis treatments, specifically designed for patients who haven't previously received biologic medications.

  • Novel Therapeutic Approaches
  • Biologic-Naive Patient Studies
  • Inflammatory Joint Disease Management

These studies aim to evaluate innovative treatment options including zasocitinib and sonelokimab for improving patient outcomes.

02 Autoimmune Conditions

Research centered on understanding and treating active psoriatic arthritis through various therapeutic mechanisms and treatment modalities.

  • Disease-Modifying Treatments
  • Inflammatory Response Studies
  • Long-term Disease Management

Current trials are exploring the efficacy of deucravacitinib and other targeted therapies in managing autoimmune manifestations.

03 Clinical Advancement

Innovative research comparing biological treatment alternatives against placebo to establish new standards in arthritis care.

  • Treatment Response Assessment
  • Patient Safety Monitoring
  • Quality of Life Improvements

These studies focus on developing safe and effective treatments for patients with active joint disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.